ASSERTIO THERAPEUTICS INC filings

SEC filings by ASSERTIO THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2021-02-12Allianz Global Investors U.S. Holdings LLCAssertio Therapeutics, Inc00.0%EDGAR
SC 13D2020-03-26Assertio Therapeutics, IncZyla Life Sciences4,854,86351.0%EDGAR
SC 13G/A2020-02-14ARMISTICE CAPITAL, LLCAssertio Therapeutics, Inc00.0%EDGAR
SC 13G/A2020-02-14D. E. SHAW & CO, L.P.Assertio Therapeutics, Inc4,506,5855.6%EDGAR
SC 13G/A2020-02-13RENAISSANCE TECHNOLOGIES LLCAssertio Therapeutics, Inc6,529,5278.1%EDGAR
SC 13G2020-02-13Allianz Global Investors U.S. Holdings LLCAssertio Therapeutics, Inc5,911,8757.3%EDGAR
SC 13G/A2020-02-12VANGUARD GROUP INCAssertio Therapeutics, Inc5,152,6826.4%EDGAR
SC 13G/A2020-02-12DIMENSIONAL FUND ADVISORS LPAssertio Therapeutics, Inc3,919,3544.9%EDGAR
SC 13G/A2020-01-10BlackRock Inc.Assertio Therapeutics, Inc5,797,4577.2%EDGAR
SC 13G2019-11-12D. E. SHAW & CO, L.P.Assertio Therapeutics, Inc4,059,4165.0%EDGAR
SC 13G/A2019-02-14ARMISTICE CAPITAL, LLCAssertio Therapeutics, Inc3,278,0005.1%EDGAR
SC 13G2019-02-12RENAISSANCE TECHNOLOGIES LLCAssertio Therapeutics, Inc4,668,5917.3%EDGAR
SC 13G/A2019-02-11VANGUARD GROUP INCAssertio Therapeutics, Inc6,422,59410.0%EDGAR
SC 13G/A2019-02-11VANGUARD GROUP INCAssertio Therapeutics, Inc6,422,59410.0%EDGAR
SC 13G/A2019-02-08Senvest Management, LLCAssertio Therapeutics, Inc2,384,3193.7%EDGAR
SC 13G/A2019-02-08VANGUARD GROUP INCAssertio Therapeutics, Inc5,482,0238.6%EDGAR
SC 13G2019-02-08DIMENSIONAL FUND ADVISORS LPAssertio Therapeutics, Inc3,948,5146.2%EDGAR
SC 13G2019-01-24BlackRock Inc.Assertio Therapeutics, Inc10,400,54216.3%EDGAR
SC 13D/A2018-05-22Starboard Value LPDEPOMED INC2,703,9954.3%EDGAR
SC 13D/A2018-05-14Starboard Value LPDEPOMED INC3,885,2956.1%EDGAR